Opioid-induced pancreatitis: A case study

Anuka Koul , Jaspreet Kaur , Sahil Attri , Navneet Arora

›› 2024, Vol. 13 ›› Issue (6) : 220 -222.

PDF (359KB)
›› 2024, Vol. 13 ›› Issue (6) :220 -222. DOI: 10.4103/jad.jad_140_23
Case Report
research-article
Opioid-induced pancreatitis: A case study
Author information +
History +
PDF (359KB)

Abstract

Rationale: Opioids, the class of drugs, frequently used for pain relief in acute pancreatitis are known to act as a dual-edged sword. They are capable of causing acute pancreatitis though very rare. Patient’s Concern: A 45-year-old male presented with complaints of acute onset, severe pain in the abdomen, radiating to the back. The symptoms were preceded by regular oral intake of opium. Diagnosis: Opioid-induced pancreatitis. Interventions: He was managed conservatively with non-opioid analgesic-acetaminophen 15 mg/kg every 6 hours along with intravenous Ringer’s lactate for 5 days. Outcomes: The patient was discharged in stable vitals. Lessons: Drug-induced pancreatitis, though a rare entity, must be dealt with a high degree of suspicion once the other common factors are ruled out. Thus, this case highlights the importance that opioids can act as a double-edged sword in the way that it is given for pain relief in patients suffering from pancreatitis and can also be the culprit in causing it.

Keywords

Acute pancreatitis / Drug-induced pancreatitis / Opioid / Toxicology

Cite this article

Download citation ▾
Anuka Koul, Jaspreet Kaur, Sahil Attri, Navneet Arora. Opioid-induced pancreatitis: A case study. , 2024, 13 (6) : 220-222 DOI:10.4103/jad.jad_140_23

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Tenner S. Drug induced acute pancreatitis: Does it exist? World J Gastroenterol 2014; 20(44): 16529.

[2]

Yokoe M, Takada T, Mayumi T, Yoshida M, Isaji S, Wada K, et al. Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. J Hepatobiliary Pancreat Sci 2015; 22(6): 405-432.

[3]

Ciobanu C, Jadav RS, Ramos AC, Gross HG, Brazzarola C. Heroin—induced acute pancreatitis. Cureus 2021; 13(6): e15470.

[4]

Hastier P, Buckley MJ, Peten EP, Demuth N, Dumas R, Demarquay JF, et al. A new source of drug—induced acute pancreatitis: Codeine. Am J Gastroenterol 2000; 95(11): 3295-3298.

[5]

Sharma SS. Sphincter of Oddi dysfunction in patients addicted to opium: An unrecognized entity. Gastrointest Endosc 2002; 55(3): 427-430.

[6]

Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol 2019; 16(3): 175-184.

[7]

Balani AR, Grendell JH. Drug—induced pancreatitis: Incidence, management and prevention. Drug Saf 2008; 31(10): 823-837.

[8]

Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug—induced acute pancreatitis: An evidence—based review. Clin Gastroenterol Hepatol 2007; 5(6): 648-661.

[9]

Hastier P, Buckley MJ, Peten EP, Demuth N, Dumas R, Demarquay JF, et al. A new source of drug—induced acute pancreatitis: Codeine. Am J Gastroenterol 2000; 95(11): 3295-3298.

[10]

Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: A review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol 2001; 96(4): 1266-1272.

PDF (359KB)

4

Accesses

0

Citation

Detail

Sections
Recommended

/